Literature DB >> 16495756

High-density lipoprotein cholesterol-raising strategies.

Jeffrey T Kuvin1, Alawi A Alsheikh-Ali, Richard H Karas.   

Abstract

There is a distinct inverse relationship between high-density lipoprotein cholesterol (HDL-C) and cardiovascular disease risk. HDL-C mediates cholesterol efflux from the vasculature and promotes anti-oxidant, anti-inflammatory, and anti-thrombotic effects. There are multiple lifestyle and therapeutic interventions that raise HDL-C, and there is increasing evidence that these interventions improve cardiovascular outcomes. Recent findings regarding the role of HDL-C in cholesterol metabolism offer new strategies designed to target atherosclerosis. This review highlights the utility of existing HDL-C-raising strategies and examines new potential therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495756     DOI: 10.1097/01.fjc.0000199684.20578.7c

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

1.  Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.

Authors:  Amir Hooshang Mohammadpour; Fatemeh Akhlaghi
Journal:  Clin Pharmacokinet       Date:  2013-08       Impact factor: 6.447

2.  High-Density Lipoprotein Biogenesis: Defining the Domains Involved in Human Apolipoprotein A-I Lipidation.

Authors:  Ricquita D Pollard; Brian Fulp; Mary G Sorci-Thomas; Michael J Thomas
Journal:  Biochemistry       Date:  2016-08-23       Impact factor: 3.162

3.  Raising HDL cholesterol in women.

Authors:  Danny J Eapen; Girish L Kalra; Luay Rifai; Christina A Eapen; Nadya Merchant; Bobby V Khan
Journal:  Int J Womens Health       Date:  2010-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.